Daihan Pharmaceutical Co., Ltd. (023910) Price & Analysis

― Followers

023910 Stock Chart & Stats

₩25650.00

₩150.00(0.59%)

Jul 30, 2026

―

Day’s Range― - ―

52-Week Range₩24,000.00 - ₩32,450.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)10.21K

Market Cap

₩149.94B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)5.5

Beta0.05

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding6,000,000

10 Day Avg. Volume8,106

30 Day Avg. Volume10,206

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)5,575

Revenue Forecast (FY)₩215.70B

023910 FAQ

What was Daihan Pharmaceutical Co., Ltd.’s price range in the past 12 months?

Daihan Pharmaceutical Co., Ltd. lowest stock price was ₩24000.00 and its highest was ₩32450.00 in the past 12 months.

What is Daihan Pharmaceutical Co., Ltd.’s market cap?

Daihan Pharmaceutical Co., Ltd.’s market cap is ₩149.94B.

When is Daihan Pharmaceutical Co., Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Daihan Pharmaceutical Co., Ltd.’s earnings last quarter?

Daihan Pharmaceutical Co., Ltd. released its earnings results on May 15, 2026. The company reported ₩1187.224 earnings per share for the quarter, beating the consensus estimate of N/A by ₩1187.224.

Is Daihan Pharmaceutical Co., Ltd. overvalued?

According to Wall Street analysts Daihan Pharmaceutical Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Daihan Pharmaceutical Co., Ltd. pay dividends?

Daihan Pharmaceutical Co., Ltd. does not currently pay dividends.

What is Daihan Pharmaceutical Co., Ltd.’s EPS estimate?

Daihan Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Daihan Pharmaceutical Co., Ltd. have?

Daihan Pharmaceutical Co., Ltd. has 6,000,000 shares outstanding.

What happened to Daihan Pharmaceutical Co., Ltd.’s price movement after its last earnings report?

Daihan Pharmaceutical Co., Ltd. reported an EPS of ₩1187.224 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.636%.

Which hedge fund is a major shareholder of Daihan Pharmaceutical Co., Ltd.?

Currently, no hedge funds are holding shares in KR:023910

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Daihan Pharmaceutical Co., Ltd.

As a pioneer in Korea's pharmaceutical landscape, Daihan Pharmaceutical Co., Ltd. was the first to produce infusions, a crucial innovation that significantly contributed to national public health. This initial achievement not only forged new pathways for other medical companies but also solidified its standing as a leading domestic manufacturer of intravenous solutions.